Market Update: Tuesday, 7 May 2019 Vectura Group plc (VEC.L) wins US GSK patent litigation | Company Update Motif Bio* (MTFB.L): Meeting with the US FDA (From Friday) | Faron Pharma (FARN.L): Annual results for 2018 Share Price: 70.5p; Mkt. Cap. £25.0m
07 May 2019
HEALTHCARE CONDITIONS
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
HEALTHCARE CONDITIONS
- Published:
07 May 2019 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
4
Market Update: Tuesday, 7 May 2019 Vectura Group plc (VEC.L) wins US GSK patent litigation | Company Update Motif Bio* (MTFB.L): Meeting with the US FDA (From Friday) | Faron Pharma (FARN.L): Annual results for 2018 Share Price: 70.5p; Mkt. Cap. £25.0m